- Home
- AHCO vs SANA Comparison
AHCO vs SANA Comparison
Compare AHCO & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AHCO | SANA |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.4M | 793.1M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AHCO | SANA |
|---|---|---|
| Price | $5.63 | $3.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $13.50 | $7.80 |
| AVG Volume (30 Days) | ★ 4.5M | 2.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,244,857,000.00 | N/A |
| Revenue This Year | $9.00 | N/A |
| Revenue Next Year | $6.93 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $2.61 |
| 52 Week High | $13.43 | $6.55 |
Technical Indicators
Market Signals| Indicator | AHCO | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 31.95 | 51.30 |
| Support Level | $5.27 | $3.03 |
| Resistance Level | $5.95 | $4.15 |
| Average True Range (ATR) | 0.24 | 0.23 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 56.35 | 46.47 |
Price Performance
Historical ComparisonAbout AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.